Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Better Biotech
  4.  » 
  5. Biologics
  6.  » A Q&A with Jim Spavins

A Q&A with Jim Spavins

Summary: In nearly 40 years at Pfizer and in consulting, Spavins has helped many scientists make the jump from academic approaches to the needs of the boardroom. We sat down with Jim Spavins, a board member of the Catalent Applied Drug Delivery Institute, to discuss what founders must consider when launching a biotech startup, how to navigate complex regulatory and funding challenges, and the benefits of partnering with trusted contract development and manufacturing organizations (CDMOs).

Download Article